Chemical engineering meets cancer immunotherapy
Sachin Bhagchandani wins NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award.
Landmark Bio, a biomanufacturing facility co-founded by MIT, breaks ground in Watertown Arsenal
Public-private partnership aims to advance development and production of medical treatments.
Biological engineers find a new target for malaria drugs
Blocking a key enzyme could kill parasites that have evolved resistance to existing drugs.
Software to accelerate R&D
The alumni-founded startup Uncountable has developed a digital workbook to help scientists get more out of experimental data.
Speeding up clinical trials by making drug production local
Professor Tim Jamison’s company Snapdragon Chemistry helps turn the latest innovations in chemistry into impactful drugs.
Behind Covid-19 vaccine development
A machine learning model developed jointly by Janssen and MIT data scientists played a key role in the clinical trial process for the Johnson & Johnson Covid-19 vaccine.
Big data dreams for tiny technologies
MIT research combines machine learning with nanoparticle design for personalized drug delivery.
Faster drug discovery through machine learning
New technique speeds up calculations of drug molecules’ binding affinity to proteins.
Chemists boost boron’s utility
A strategy for preventing boron-containing compounds from breaking down could help medicinal chemists design new drugs.
A machine-learning approach to finding treatment options for Covid-19
Researchers develop a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients.
RNA molecules are masters of their own destiny
Research suggests the products of transcription — RNA molecules — regulate their own production through a feedback loop.
Turning microbiome research into a force for health
A diverse group of researchers is working to turn new discoveries about the trillions of microbes in the body into treatments for a range of diseases.
Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
SMART researchers use lysins to selectively target bacteria
The discovery can help to cure bacterial infections without inducing resistance or causing harm to good bacteria.
MIT launches Center for Multi-Cellular Engineered Living Systems
M-CELS are purpose-driven living systems with multiple interacting living components.